NSC |
Compound |
Enrichment |
Correlation |
NSC 37186 |
Null |
0.000588249147782811 |
0.41723894 |
NSC 619321 |
Null |
0.000588249147782811 |
-0.0046556671 |
NSC 305802 |
2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- |
0.000649370174092101 |
0.16225023 |
NSC 618932 |
Null |
0.000649370174092101 |
0.45363254 |
NSC 663792 |
Null |
0.000649370174092101 |
0.090787563 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.000649370174092101 |
0.27835074 |
NSC 164970 |
Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- |
0.000710545569439728 |
0.39048726 |
NSC 178248 |
Chlorozotocin |
0.000710545569439728 |
0.24530911 |
NSC 688995 |
Null |
0.000710545569439728 |
0.20609224 |
NSC 744469 |
3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate |
0.000710545569439728 |
0.25870806 |